Cogent Biosciences (COGT) has had the highest return since October 31, 2025 by a mid-cap US stock, returning 107.8%.
| ASSET | % RETURN |
|---|---|
Cogent Biosciences (COGT) | 107.8% |
Haemonetics (HAE) | 49.07% |
Appian (APPN) | 44.71% |
Baytex Energy (BTE) | 40.81% |
McGraw Hill (MH) | 37.21% |
Comstock Resources (CRK) | 34.57% |
Paymentus (PAY) | 31.36% |
Progyny (PGNY) | 30.45% |
10X Genomics (TXG) | 30.18% |
Teradata (TDC) | 28.97% |
Lifestance Health (LFST) | 28.78% |
Globalstar, Inc Common Stock (GSAT) | 28.28% |
Sealed Air (SEE) | 27.4% |
Compass (COMP) | 27.04% |
ePlus (PLUS) | 26.63% |
Jfrog (FROG) | 26.1% |
Kennametal (KMT) | 24.84% |
Aurinia Pharmaceuticals (AUPH) | 24.65% |
Warrior Met Coal (HCC) | 23.78% |
LandBridge Company LLC (LB) | 23.37% |
Seaboard (SEB) | 22.47% |
Xometry (XMTR) | 22.05% |
Clear Secure (YOU) | 21.53% |
Hagerty (HGTY) | 21.53% |
Accelerant (ARX) | 21.34% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
